PEPTIDE CORPUS

Mechanism of Action

Melanocortin-Independent Anti-Inflammation

Last updated

Anti-inflammatory action reported not to run through the melanocortin receptors, even where the compound is a fragment of a melanocortin hormone. The described effects are on inflammatory signalling inside the cell, including reduced NF-kB activity and lower output of inflammatory cytokines. The exact target is often not identified, which is what the name concedes: it states where the action is not.

Why it matters here

A mechanism named for what it excludes is a useful honesty signal. It tells you the melanocortin-receptor evidence does not transfer to this claim, so the two must be graded as separate rows.

What it is not

Do not read this as a fully characterised mechanism. Melanocortin-independent is a negative result about one route, not a positive identification of another, and a compound can be filed here simply because blocking melanocortin receptors failed to abolish the effect.

Also called

The aliases inflammation resolution and cytokine suppression are general anti-inflammatory language. They describe effects rather than naming this specific finding, and they appear in the literature for compounds with nothing to do with melanocortins.

Compounds carrying this term

None on file yet. This term is in the controlled vocabulary but no compound record currently uses it — which is a statement about our coverage, not about the term.

See also